In response to the release of the movie Contagion, which chronicles a fictitious global disease pandemic, GHTC Director Kaitlin Christenson writes in The Hill about the real world threat of infectious diseases and the critical importance of investing in the development of new vaccines, diagnostics, drugs, and other health tools to counter these threats.
Nature examines the impact of the passage of the US Budget Control Act, which will usher in cuts to US global health funding. GHTC Director Kaitlin Christenson is quoted, noting that these cuts could slow or halt momentum in developing critically needed global health technologies.
The Journal of the American Medical Association (JAMA) reports on the release of GHTC's annual policy report Sparking innovation to save lives. The article focuses on the domestic and international benefits of US global health R&D investment and notes many of the promising US-funded technologies under development.
In an op-ed in Roll Call, GHTC Director Kaitlin Christenson and former Congressman Michael Castle (R-DE) reflect on the progress achieved in global health product development as a result of US investment and innovative product development partnerships, and warn that budget cuts could put this momentum at risk.